Dr. Richard Williams
B. Med Sc., MBBS, PhD
Dr. Shannon T. Bailey
M.S., M.Phil, PhD
Want to harness genomic big data to propel drug discovery, clinical diagnoses, population health, and precision medicine?
March 31, 3:30pm – 4:30pm | Theater B
Please join us for the Exhibitor Spotlight Theater session presented by Dr. Richard Williams Managing Director and Head of Oncology Programs, WuXi NextCODE, and Dr. Qunsheng Ji VP and Head of Oncology & Immunology, WuXi AppTec.
Qunsheng Ji, MD, PhD
VP & Head of Oncology & Immunology, WuXi AppTec
Despite significant clinical advancements in a broad-range of tumor types, a majority of patients don’t respond to immune checkpoint inhibitor therapies such as anti-PD-1 and anti-PD-L1. This presentation will review potentially useful emerging technologies for IO drug discovery including in vivo CRISPR screen, preclinical assays & disease models and immune-profiling.
Richard Williams, MBBS, PhD
Managing Director, Head of Oncology Programs, WuXi NextCODE
At WuXi NextCODE, to drive next generation cancer drug target discovery, we leverage SeqPlus, our proprietary method for very even WGS from archival FFPE specimens, integrate massive WGS, RNA-transcriptome, DNA-methylation datasets and apply advanced AI to large collections of archival FFPE tissue specimens with phenotypic and outcomes data.